MedCity News June 24, 2021
Elise Reuter

Direct-to-consumer health startup Hims bought dermatology business Apostrophe. It’s part of a broader push by the company to expand into more indications.

Direct-to-consumer health startup Hims & Hers is buying a dermatology business. The company recently struck a deal to buy Apostrophe, which has a similar business model, for an undisclosed amount.

Oakland, Calif.-based Apostrophe sells prescription acne treatments, such as topical creams and pills. It also offers treatments for wrinkles, rosacea and hair loss.

Like with Hims, users conduct a virtual consultation with a dermatologist, including filling out a questionnaire and sending in images of their skin, before getting a prescription delivered. Apostrophe contracts with an outside physician group for the visits, which cost about $20. The company is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Mergers & Acquisitions / JV, Technology, Trends
Embracing digital transformation with a digital factory
Why Should Payers Spend Money on Digital Diabetes Solutions?
How Remote Patient Monitoring and AI Personalize Care
Digital Platforms Streamline Medication Access and Delivery
Too much data? Wearables for senior care have value but providers must know how to parse their output, experts say

Share This Article